Please find enclosed herewith Outcome of the board meeting for your information.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At a board meeting held on May 12, 2025 (3:00 PM to 3:45 PM), Boston Bio Systems Limited accepted the resignations of four key personnel: Managing Director Mr. Pratik Satish Patil, Additional Director Ms. Seema Baghel, Director Ms. Sadhana Satish Patil, and CFO Ms. Manpreet Doad Powani — all citing personal pre-occupations. The board then appointed Mr. VishnuBhai Desai (real estate background) as the new Managing Director, Mr. Kunjan Nathabhai Rathod (transport/logistics background) as the new CFO, and Mr. Yash Arun Chaudhary as an Additional Non-Executive Non-Independent Director. Mr. Ghanshyam Dhananjay Gavali was redesignated from Non-Executive Independent Director to Executive Director. The board also reconstituted its Audit, Nomination & Remuneration, and Stakeholders' Relationship Committees with effect from the same date.
This is a significant top-level management reshuffle — the company has a completely new MD and CFO, with several other board changes. Shareholders should monitor for any shift in business strategy or governance quality, given that the new MD comes from real estate and the new CFO from transport/logistics, neither with apparent biosystems background.